semiskilled
发表于 2025-3-30 10:32:03
http://reply.papertrans.cn/67/6669/666842/666842_51.png
哭得清醒了
发表于 2025-3-30 14:20:27
http://reply.papertrans.cn/67/6669/666842/666842_52.png
crease
发表于 2025-3-30 19:10:55
http://reply.papertrans.cn/67/6669/666842/666842_53.png
掺假
发表于 2025-3-30 20:41:06
Non-invasive Diagnostic Approach to NASH: Biological Markers, 2 diabetes, accounting for the most growing cause of chronic liver disease, of hepatocellular carcinoma and of end-stage liver disease leading to liver transplantation. Natural history studies clearly demonstrated that among NAFLD population, those with non-alcoholic steatohepatitis (NASH) have a d
aneurysm
发表于 2025-3-31 03:21:29
Noninvasive Diagnostic Approach to NASH: Radiological Diagnostics,r disease worldwide given the obesity epidemic. Unlike many other forms of chronic liver disease that have simple, highly accurate diagnostic algorithms, NAFLD and, in particular, NASH can be quite challenging to diagnose noninvasively. In this setting, identification of noninvasive biomarkers with
Habituate
发表于 2025-3-31 06:54:02
Dietary Approach to NAFLD,ction could be three main ways to avoid disease progression. .: Systematic Review of manuscripts published addressing diet and NAFLD. .: Macronutrients such as saturated fatty acids (SFA), trans-fats, simple sugars, and animal proteins have a harmful effect on the liver. Monounsaturated fats (MUFAs)
Prognosis
发表于 2025-3-31 09:28:13
Physical Activity in NAFLD: What and How Much?,ally alongside weight loss and dietary change. Physical activity and exercise have both been shown to improve liver health in NAFLD and should be included as part of the clinical care of all patients, regardless of where they sit on the NAFLD disease spectrum [.]. Reducing or breaking up sedentary t
ABASH
发表于 2025-3-31 15:25:33
http://reply.papertrans.cn/67/6669/666842/666842_58.png
SHOCK
发表于 2025-3-31 19:36:45
http://reply.papertrans.cn/67/6669/666842/666842_59.png
Gratuitous
发表于 2025-4-1 00:02:14
Liver Transplantation and NAFLD/NASH,reasingly common indications for liver transplantation (LT), both for end-stage liver disease and for hepatocellular carcinoma. NASH patients who are candidates to LT present peculiar issues as they are frequently overweight and have features of metabolic syndrome with associated comorbidities. Thus